ALTACE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Ramipril.
Product ID | 61570-111_7c58ba31-97ac-4b94-93c7-d6c9868df832 |
NDC | 61570-111 |
Product Type | Human Prescription Drug |
Proprietary Name | ALTACE |
Generic Name | Ramipril |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1991-01-28 |
Marketing Category | NDA / NDA |
Application Number | NDA019901 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | RAMIPRIL |
Active Ingredient Strength | 3 mg/1 |
Pharm Classes | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 1991-01-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019901 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1991-01-28 |
Marketing Category | NDA |
Application Number | NDA019901 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1991-01-28 |
Marketing End Date | 2011-07-31 |
Marketing Category | NDA |
Application Number | NDA019901 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1991-01-28 |
Marketing End Date | 2011-07-31 |
Marketing Category | NDA |
Application Number | NDA019901 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1991-01-28 |
Marketing End Date | 2011-07-31 |
Ingredient | Strength |
---|---|
RAMIPRIL | 2.5 mg/1 |
SPL SET ID: | 0fc34cd8-86e6-4034-73bd-4263a68ba046 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
61570-120 | ALTACE | ALTACE |
61570-110 | ALTACE | ALTACE |
61570-112 | ALTACE | ALTACE |
61570-111 | ALTACE | ALTACE |
0054-0106 | Ramipril | Ramipril |
0054-0107 | Ramipril | Ramipril |
0054-0108 | Ramipril | Ramipril |
0054-0109 | Ramipril | Ramipril |
10544-588 | Ramipril | Ramipril |
16729-152 | Ramipril | Ramipril |
16729-153 | Ramipril | Ramipril |
16729-154 | Ramipril | Ramipril |
16729-155 | Ramipril | Ramipril |
17856-0108 | RAMIPRIL | RAMIPRIL |
21695-821 | Ramipril | ramipril |
21695-822 | Ramipril | ramipril |
21695-823 | Ramipril | ramipril |
31722-271 | Ramipril | Ramipril |
31722-272 | Ramipril | Ramipril |
31722-273 | Ramipril | Ramipril |
31722-274 | Ramipril | Ramipril |
33261-903 | Ramipril | Ramipril |
33261-967 | Ramipril | Ramipril |
42291-692 | Ramipril | Ramipril |
43063-303 | Ramipril | Ramipril |
43063-502 | Ramipril | Ramipril |
45865-441 | Ramipril | Ramipril |
45865-443 | Ramipril | Ramipril |
50090-1118 | Ramipril | Ramipril |
50090-1120 | Ramipril | Ramipril |
50090-1354 | Ramipril | Ramipril |
50090-2169 | Ramipril | Ramipril |
50090-2577 | Ramipril | Ramipril |
50090-3059 | Ramipril | Ramipril |
50090-3873 | Ramipril | Ramipril |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ALTACE 76171261 2552254 Dead/Cancelled |
King Pharmaceuticals, Inc. 2000-11-27 |
ALTACE 74092062 1812659 Live/Registered |
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC 1990-08-28 |